PT86255B - Processo para a preparacao de derivados de azol - Google Patents

Processo para a preparacao de derivados de azol Download PDF

Info

Publication number
PT86255B
PT86255B PT86255A PT8625587A PT86255B PT 86255 B PT86255 B PT 86255B PT 86255 A PT86255 A PT 86255A PT 8625587 A PT8625587 A PT 8625587A PT 86255 B PT86255 B PT 86255B
Authority
PT
Portugal
Prior art keywords
formula
addition salt
compound
acid addition
pharmaceutically acceptable
Prior art date
Application number
PT86255A
Other languages
English (en)
Portuguese (pt)
Other versions
PT86255A (en
Inventor
Helmut Egger
Rudolf Walchli
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT86255A publication Critical patent/PT86255A/pt
Publication of PT86255B publication Critical patent/PT86255B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PT86255A 1986-12-03 1987-12-02 Processo para a preparacao de derivados de azol PT86255B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3641320 1986-12-03

Publications (2)

Publication Number Publication Date
PT86255A PT86255A (en) 1988-06-01
PT86255B true PT86255B (pt) 1990-11-07

Family

ID=6315380

Family Applications (1)

Application Number Title Priority Date Filing Date
PT86255A PT86255B (pt) 1986-12-03 1987-12-02 Processo para a preparacao de derivados de azol

Country Status (24)

Country Link
JP (1) JPH0678318B2 (xx)
KR (1) KR880007481A (xx)
AT (1) AT395587B (xx)
AU (1) AU605522B2 (xx)
BE (1) BE1001235A4 (xx)
CH (1) CH677925A5 (xx)
DK (1) DK631287A (xx)
ES (1) ES2010235A6 (xx)
FI (1) FI875300A (xx)
FR (1) FR2607810B1 (xx)
GB (1) GB2199579B (xx)
GR (1) GR871897B (xx)
HU (1) HU198694B (xx)
IL (1) IL84665A (xx)
IT (1) IT1211944B (xx)
LU (1) LU87063A1 (xx)
MY (1) MY103004A (xx)
NL (1) NL8702897A (xx)
NZ (1) NZ222765A (xx)
PH (1) PH24666A (xx)
PL (1) PL151588B1 (xx)
PT (1) PT86255B (xx)
SE (1) SE8704792L (xx)
ZA (1) ZA879093B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814277D0 (en) * 1988-06-16 1988-07-20 Glaxo Group Ltd Chemical compounds
UA41295C2 (uk) * 1991-09-02 2001-09-17 Яманугі Фармасетікл Ко., Лтд Триазолілзаміщені третинні амінні сполуки або їх солі як інгібітор ароматази та фармацевтична композиція на їх основі
GB9409882D0 (en) * 1994-05-18 1994-07-06 Sandoz Ltd Organic compounds
GB0128415D0 (en) * 2001-11-27 2002-01-16 Univ Sheffield Medicaments

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT382868B (de) * 1983-03-11 1987-04-27 Sandoz Ag Verfahren zur herstellung neuer azolderivate und deren salze
JPH0625144B2 (ja) * 1986-02-24 1994-04-06 四国化成工業株式会社 新規イミダゾール化合物及び該化合物の合成方法

Also Published As

Publication number Publication date
LU87063A1 (fr) 1988-07-14
AU8196287A (en) 1988-06-16
AU605522B2 (en) 1991-01-17
FR2607810B1 (fr) 1989-12-01
SE8704792L (sv) 1988-06-04
IL84665A (en) 1991-11-21
FI875300A0 (fi) 1987-12-01
JPS63145270A (ja) 1988-06-17
IT8748656A0 (it) 1987-12-01
PL151588B1 (en) 1990-09-28
NL8702897A (nl) 1988-07-01
MY103004A (en) 1993-03-31
ES2010235A6 (es) 1989-11-01
GB8727978D0 (en) 1988-01-06
DK631287A (da) 1988-06-04
IT1211944B (it) 1989-11-08
JPH0678318B2 (ja) 1994-10-05
ATA316887A (de) 1992-06-15
AT395587B (de) 1993-01-25
BE1001235A4 (fr) 1989-08-29
GB2199579A (en) 1988-07-13
KR880007481A (ko) 1988-08-27
PT86255A (en) 1988-06-01
NZ222765A (en) 1990-11-27
FR2607810A1 (fr) 1988-06-10
ZA879093B (en) 1989-07-26
PL269180A1 (en) 1988-08-18
GR871897B (en) 1988-04-04
PH24666A (en) 1990-09-07
HUT45506A (en) 1988-07-28
FI875300A (fi) 1988-06-04
DK631287D0 (da) 1987-12-01
IL84665A0 (en) 1988-05-31
CH677925A5 (xx) 1991-07-15
GB2199579B (en) 1990-07-18
SE8704792D0 (sv) 1987-12-01
HU198694B (en) 1989-11-28

Similar Documents

Publication Publication Date Title
BR112020012329A2 (pt) antagonistas de tlr7/8 e usos dos mesmos
CN103189361B (zh) 雌激素受体调节剂及其用途
JP7142577B2 (ja) ビスフェノール誘導体、及びアンドロゲン受容体活性調節因子としてのそれらの使用
ES2907708T3 (es) Compuestos heterocíclicos para obtención de imágenes y tratamiento del cáncer y métodos para su uso
ES2380653T3 (es) Complejos de inclusión de Beta-ciclodextrina-drospirenona
CN105339358A (zh) 核转运调节剂及其用途
BRPI0909564B1 (pt) uso de um composto
US6248780B1 (en) Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same
ES2959891T3 (es) Producción de trans-[tetraclorobis(1H-indazol)rutenato (III)] y composiciones del mismo
JPS6330309B2 (xx)
BR112021015618A2 (pt) Derivados de amida úteis no tratamento da infecção pelo hbv ou doenças induzidas pelo hbv
US6933315B2 (en) Derivatives of isoindigo, indigo and indirubin and methods of treating cancer
PT728140E (pt) Novos esteroides com grupos substituintes com propriedades de captura de radicais, processo para a sua preparacao e medicamentos que contem estes compostos
PT86255B (pt) Processo para a preparacao de derivados de azol
PT96864A (pt) Processo para a preparacao de derivados de benzofurano
CN107922448B (zh) 一种氘代噻吩并哌啶衍生物、制备方法及其应用
PT99738B (pt) Processo para a preparacao de compostos de fluor contendo por exemplo um grupo triazolilo
CN110343070B (zh) 一种微管蛋白抑制剂及其制备方法与应用
PT94884B (pt) Processo para a preparacao de cicloalquilenazois e de composicoes farmaceuticas que os contem
Han et al. Structure-based design of marine-derived Meridianin C derivatives as glycogen synthase kinase 3β inhibitors with improved oral bioavailability: From aminopyrimidyl-indoles to the sulfonyl analogues
PT92324A (pt) Processo para a preparacao de oxadiaminobutanos substituidos
BR112020009737A2 (pt) composições estáveis de compostos de carfilzomib peguilados
JPH05320049A (ja) アゾール誘導体を含有する抗アロマターゼ剤
US3898331A (en) 4{40 -Dehydro-oleandrin and pharmaceutical composition thereof
CN104610149B (zh) 一种茚并吡唑类小分子微管蛋白抑制剂及其制备方法与应用

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19940930